DYNEX CAPITAL INC (DX) Stock Fundamental Analysis

NYSE:DX • US26817Q8868

14.05 USD
-0.05 (-0.35%)
At close: Feb 13, 2026
14.1 USD
+0.05 (+0.36%)
After Hours: 2/13/2026, 8:04:11 PM
Fundamental Rating

4

Taking everything into account, DX scores 4 out of 10 in our fundamental rating. DX was compared to 70 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. DX has a medium profitability rating, but doesn't score so well on its financial health evaluation. DX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DX had positive earnings in the past year.
  • In the past year DX had a positive cash flow from operations.
  • DX had positive earnings in 4 of the past 5 years.
  • Of the past 5 years DX 4 years had a positive operating cash flow.
DX Yearly Net Income VS EBIT VS OCF VS FCFDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • DX has a better Return On Assets (1.24%) than 87.14% of its industry peers.
  • DX has a Return On Equity of 8.96%. This is amongst the best in the industry. DX outperforms 92.86% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.18%, DX is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA 1.24%
ROE 8.96%
ROIC 0.18%
ROA(3y)0.95%
ROA(5y)1.82%
ROE(3y)6.64%
ROE(5y)9.35%
ROIC(3y)N/A
ROIC(5y)N/A
DX Yearly ROA, ROE, ROICDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1.3 Margins

  • DX has a Profit Margin of 39.43%. This is amongst the best in the industry. DX outperforms 94.29% of its industry peers.
  • DX's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 7.21%, DX is in line with its industry, outperforming 41.43% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DX has declined.
  • Looking at the Gross Margin, with a value of 17.47%, DX is doing worse than 78.57% of the companies in the same industry.
  • DX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.21%
PM (TTM) 39.43%
GM 17.47%
OM growth 3Y-84.94%
OM growth 5Y-23.27%
PM growth 3YN/A
PM growth 5Y-18.98%
GM growth 3Y-77.72%
GM growth 5Y-20.2%
DX Yearly Profit, Operating, Gross MarginsDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K -2K -4K

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DX is destroying value.
  • Compared to 1 year ago, DX has more shares outstanding
  • The number of shares outstanding for DX has been increased compared to 5 years ago.
  • Compared to 1 year ago, DX has about the same debt to assets ratio.
DX Yearly Shares OutstandingDX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DX Yearly Total Debt VS Total AssetsDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of -0.83, we must say that DX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.83, DX is doing worse than 78.57% of the companies in the same industry.
  • The Debt to FCF ratio of DX is 96.76, which is on the high side as it means it would take DX, 96.76 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 96.76, DX is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
  • A Debt/Equity ratio of 6.01 is on the high side and indicates that DX has dependencies on debt financing.
  • DX has a Debt to Equity ratio (6.01) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 6.01
Debt/FCF 96.76
Altman-Z -0.83
ROIC/WACC0.03
WACC5.85%
DX Yearly LT Debt VS Equity VS FCFDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • DX has a Current Ratio of 0.05. This is a bad value and indicates that DX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.05, DX is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
  • DX has a Quick Ratio of 0.05. This is a bad value and indicates that DX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.05, DX is doing worse than 78.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
DX Yearly Current Assets VS Current LiabilitesDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 328.57% over the past year.
  • DX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.04% yearly.
  • Looking at the last year, DX shows a very strong growth in Revenue. The Revenue has grown by 67.76%.
  • DX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.77% yearly.
EPS 1Y (TTM)328.57%
EPS 3Y-4.72%
EPS 5Y-13.04%
EPS Q2Q%180%
Revenue 1Y (TTM)67.76%
Revenue growth 3YN/A
Revenue growth 5Y40.77%
Sales Q2Q%531.39%

3.2 Future

  • DX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.23% yearly.
  • DX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.29% yearly.
EPS Next Y52%
EPS Next 2Y21.24%
EPS Next 3Y17.23%
EPS Next 5YN/A
Revenue Next Year134.14%
Revenue Next 2Y44.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DX Yearly Revenue VS EstimatesDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 100M 200M 300M 400M 500M
DX Yearly EPS VS EstimatesDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

5

4. Valuation

4.1 Price/Earnings Ratio

  • DX is valuated correctly with a Price/Earnings ratio of 14.64.
  • Compared to the rest of the industry, the Price/Earnings ratio of DX is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.19. DX is valued slightly cheaper when compared to this.
  • DX is valuated reasonably with a Price/Forward Earnings ratio of 9.63.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DX is on the same level as its industry peers.
  • DX is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.64
Fwd PE 9.63
DX Price Earnings VS Forward Price EarningsDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DX is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.97
EV/EBITDA 85.75
DX Per share dataDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • DX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DX's earnings are expected to grow with 17.23% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y21.24%
EPS Next 3Y17.23%

5

5. Dividend

5.1 Amount

  • DX has a Yearly Dividend Yield of 14.47%, which is a nice return.
  • DX's Dividend Yield is rather good when compared to the industry average which is at 10.29. DX pays more dividend than 90.00% of the companies in the same industry.
  • DX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 14.47%

5.2 History

  • The dividend of DX decreases each year by -11.72%.
  • DX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.72%
Div Incr Years0
Div Non Decr Years0
DX Yearly Dividends per shareDX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 115.43% of the earnings are spent on dividend by DX. This is not a sustainable payout ratio.
DP115.43%
EPS Next 2Y21.24%
EPS Next 3Y17.23%
DX Yearly Income VS Free CF VS DividendDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
DX Dividend Payout.DX Dividend Payout, showing the Payout Ratio.DX Dividend Payout.PayoutRetained Earnings

DYNEX CAPITAL INC

NYSE:DX (2/13/2026, 8:04:11 PM)

After market: 14.1 +0.05 (+0.36%)

14.05

-0.05 (-0.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)01-26
Earnings (Next)04-20
Inst Owners46.56%
Inst Owner Change3.11%
Ins Owners0.75%
Ins Owner Change-0.84%
Market Cap3.40B
Revenue(TTM)533.52M
Net Income(TTM)175.44M
Analysts82.86
Price Target15.4 (9.61%)
Short Float %5.99%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield 14.47%
Yearly Dividend1.67
Dividend Growth(5Y)-11.72%
DP115.43%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-21
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.74%
Min EPS beat(2)-31.42%
Max EPS beat(2)-22.06%
EPS beat(4)1
Avg EPS beat(4)-5.99%
Min EPS beat(4)-31.42%
Max EPS beat(4)42.78%
EPS beat(8)2
Avg EPS beat(8)-60.82%
EPS beat(12)2
Avg EPS beat(12)-165.76%
EPS beat(16)2
Avg EPS beat(16)-127.07%
Revenue beat(2)0
Avg Revenue beat(2)-1.86%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-20%
Min Revenue beat(4)-51.61%
Max Revenue beat(4)-1.62%
Revenue beat(8)2
Avg Revenue beat(8)-96.68%
Revenue beat(12)4
Avg Revenue beat(12)-54%
Revenue beat(16)5
Avg Revenue beat(16)-40.03%
PT rev (1m)5.23%
PT rev (3m)5.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.51%
EPS NY rev (1m)-0.41%
EPS NY rev (3m)-15.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.64
Fwd PE 9.63
P/S 7.65
P/FCF 27.97
P/OCF 27.97
P/B 1.74
P/tB 1.74
EV/EBITDA 85.75
EPS(TTM)0.96
EY6.83%
EPS(NY)1.46
Fwd EY10.39%
FCF(TTM)0.5
FCFY3.58%
OCF(TTM)0.5
OCFY3.58%
SpS1.84
BVpS8.08
TBVpS8.08
PEG (NY)0.28
PEG (5Y)N/A
Graham Number13.21
Profitability
Industry RankSector Rank
ROA 1.24%
ROE 8.96%
ROCE 1.61%
ROIC 0.18%
ROICexc 0.19%
ROICexgc 0.19%
OM 7.21%
PM (TTM) 39.43%
GM 17.47%
FCFM 27.34%
ROA(3y)0.95%
ROA(5y)1.82%
ROE(3y)6.64%
ROE(5y)9.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-23.81%
ROICexc growth 3YN/A
ROICexc growth 5Y-23.73%
OM growth 3Y-84.94%
OM growth 5Y-23.27%
PM growth 3YN/A
PM growth 5Y-18.98%
GM growth 3Y-77.72%
GM growth 5Y-20.2%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 6.01
Debt/FCF 96.76
Debt/EBITDA 344.52
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.11
Cash Conversion 356.05%
Profit Quality 69.35%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.83
F-Score4
WACC5.85%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)328.57%
EPS 3Y-4.72%
EPS 5Y-13.04%
EPS Q2Q%180%
EPS Next Y52%
EPS Next 2Y21.24%
EPS Next 3Y17.23%
EPS Next 5YN/A
Revenue 1Y (TTM)67.76%
Revenue growth 3YN/A
Revenue growth 5Y40.77%
Sales Q2Q%531.39%
Revenue Next Year134.14%
Revenue Next 2Y44.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y178.59%
EBIT growth 3YN/A
EBIT growth 5Y8.01%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y668.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y668.97%
OCF growth 3YN/A
OCF growth 5YN/A

DYNEX CAPITAL INC / DX FAQ

What is the ChartMill fundamental rating of DYNEX CAPITAL INC (DX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DX.


Can you provide the valuation status for DYNEX CAPITAL INC?

ChartMill assigns a valuation rating of 5 / 10 to DYNEX CAPITAL INC (DX). This can be considered as Fairly Valued.


What is the profitability of DX stock?

DYNEX CAPITAL INC (DX) has a profitability rating of 4 / 10.


What are the PE and PB ratios of DYNEX CAPITAL INC (DX) stock?

The Price/Earnings (PE) ratio for DYNEX CAPITAL INC (DX) is 14.64 and the Price/Book (PB) ratio is 1.74.


What is the financial health of DYNEX CAPITAL INC (DX) stock?

The financial health rating of DYNEX CAPITAL INC (DX) is 1 / 10.